Abstract

INTEGRATED APPROACH TO PRECLINICAL STUDIES AND PHARMACOLOGICAL SCREENING

R. Padma*, B. Chilakamma, G. Srinivasrao, A. Anjani, A. Nagarjuna Reddy

Abstract

Preclinical research forms the foundation of drug discovery and development, requiring a strong understanding of experimental design, ethical principles, and statistical analysis. The modules collectively provide a comprehensive overview of key concepts involved in preclinical studies. They begin with the fundamentals of biostatistics, emphasizing its role in designing scientifically sound experiments, minimizing bias, analyzing biological data, and ensuring reliable interpretation of results. Various types of data encountered in preclinical research are discussed, along with methods for data summarization, descriptive statistics, normality assessment, and appropriate selection of parametric and non-parametric statistical tests. The principles of hypothesis testing and result interpretation are highlighted to support evidence-based decision-making. The modules further explore modern approaches in drug discovery, including combinatorial chemistry and high-throughput screening, which enable rapid identification of potential drug candidates. Ethical and regulatory aspects of animal experimentation are addressed, focusing on CPCSEA guidelines, animal welfare, and responsibilities of researchers in maintaining ethical standards. Additionally, the importance of animal house management, anesthesia, analgesia, and humane handling of laboratory animals is outlined to ensure both scientific validity and ethical compliance. Overall, these modules integrate statistical rigor, innovative drug discovery techniques, and ethical responsibility, providing a strong framework for conducting high-quality, reproducible, and ethically sound preclinical research.

Keywords: guidelines; 3Rs principle (Replacement, Reduction, Refinement); Pharmacokinetics (ADME); Investigation: Preclinical research; Biostatistics; Drug discovery; Toxicity studies; Safety pharmacology; Animal models; CPCSEA New Drug (IND); Regulatory.